Back
NeuroBo Pharmaceuticals Vs. Cytokinetics Industry Stock Comparison
Sell
19
NRBO
NeuroBo Pharmaceuticals
Last Price:
2.51
Seasonality Move:
-18.3%
Sell
45
CYTK
Cytokinetics
Last Price:
51.50
Seasonality Move:
12.68%
Sell
19
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?
- The current NeuroBo Pharmaceuticals [NRBO] share price is $2.53. The Score for NRBO is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- NRBO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics a Buy, Sell or Hold?
- The current Cytokinetics [CYTK] share price is $51.48. The Score for CYTK is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NRBO Stock Price Chart
What is NeuroBo Pharmaceuticals's stock price today?
-
The NeuroBo Pharmaceuticals share price today is $2.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing slight selling pressure.
CYTK Stock Price Chart
What is Cytokinetics's stock price today?
-
The Cytokinetics share price today is $51.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight selling pressure.
NRBO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 37.53 | Sell |
Chaikin Money Flow: | -23959 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.57 - 2.91) | Sell |
Bollinger Bands (100): | (2.96 - 4.32) | Sell |
CYTK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.85 | Sell |
Relative Strength Index (14 RSI): | 41.63 | Sell |
Chaikin Money Flow: | -67058 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.89 - 55.13) | Sell |
Bollinger Bands (100): | (52.84 - 56.94) | Sell |
NRBO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.71 | Sell |
20-day SMA: | 2.72 | Sell |
50-day SMA: | 3.11 | Sell |
200-day SMA: | 3.94 | Sell |
8-day EMA: | 2.68 | Sell |
20-day EMA: | 2.78 | Sell |
50-day EMA: | 3.08 | Sell |
200-day EMA: | 5.03 | Sell |
CYTK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.65 | Sell |
20-day SMA: | 53.37 | Sell |
50-day SMA: | 54.24 | Sell |
200-day SMA: | 61.44 | Sell |
8-day EMA: | 51.93 | Sell |
20-day EMA: | 52.86 | Sell |
50-day EMA: | 53.98 | Sell |
200-day EMA: | 55.62 | Sell |
NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cytokinetics Earnings Growth & CYTK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.
NeuroBo Pharmaceuticals Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cytokinetics Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |